Thursday, January 8, 2015

Nuvilex Name Changed to PharmaCyte Biotech, Inc. and is Undervalued

The name change for ticker symbol NVLX was changed on January 7th (it was announced) to PharmaCyte Biotech Inc. and is currently trading at only 19 cents per share while the high of the year has been 62 cents per Yahoo! Finance.

The stock may be undervalued at these levels since the 52 week range indicates that it is way closer to the low than the high.  It is up 3% today.   This stock is on watch here by the blog.

What are your thoughts on this stock?

I have no position in NVLX.

No comments:

Post a Comment